FRE 📈 Fresenius SE & Co. KGaA - Overview

Fresenius SE & Co. KGaA is a multinational healthcare company that specializes in providing a wide range of products and services to patients with chronic illnesses. The company's operations are divided into four distinct segments, each catering to specific healthcare needs. The Fresenius Medical Care segment, for instance, focuses on patients with chronic kidney failure, offering a comprehensive range of dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. This segment plays a critical role in helping patients manage their condition and improve their quality of life.

The Fresenius Kabi segment, on the other hand, is dedicated to the therapy and care of critically and chronically ill patients. This segment offers a diverse portfolio of products, including I.V. generic drugs, biosimilar drugs for autoimmune diseases and oncology, enteral and parenteral nutrition products, and medical technologies. Additionally, it provides disposables, infusions pumps, apheresis machines, cell therapy devices, and other essential products that cater to the complex needs of patients. By providing these products and services, Fresenius Kabi helps healthcare professionals deliver high-quality care and improves patient outcomes.

The Fresenius Helios segment operates a network of clinical and nursing care facilities, providing patients with access to a broad range of medical services and care. This segment is committed to delivering exceptional patient care, leveraging its expertise and resources to improve health outcomes and enhance the overall patient experience. Meanwhile, the Fresenius Vamed segment offers a range of services to hospitals and other healthcare facilities, including operational management and patient care services. By providing these services, Fresenius Vamed helps healthcare facilities optimize their operations, reduce costs, and improve the quality of care they deliver.

With a rich history dating back to 1912, Fresenius SE & Co. KGaA has evolved into a leading global healthcare company, headquartered in Bad Homburg vor der Höhe, Germany. The company's commitment to innovation, quality, and patient care has earned it a reputation as a trusted partner in the healthcare industry. Today, Fresenius SE & Co. KGaA is listed on the XETRA stock exchange under the ticker symbol FRE, and its common stock is traded under the ISIN code DE0005785604, classified as a Health Care Facilities company within the GICS Sub Industry.